Eur Rev Med Pharmacol Sci 2020; 24 (21): 11409-11420

DOI: 10.26355/eurrev_202011_23634

Diabetes and COVID-19: a major challenge in pandemic period?

C. Chakraborty, A.R. Sharma, M. Bhattacharya, G. Sharma, G. Agoramoorthy, S.-S. Lee

Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, India. drchiranjib@yahoo.com


OBJECTIVE: Diabetes is a lifestyle disease and it has become an epidemic worldwide in recent decades. In the ongoing COVID-19 pandemic situation, diabetes has become a serious health concern since large numbers of patients are vulnerable to die from the virus. Thus, diabetic patients affected by COVID-19 cause a major health crisis now. Reports show that large occurrence of diabetes makes it a serious comorbidity in COVID-19 patients.

MATERIALS AND METHODS: It is crucial to understand how COVID-19 affects diabetes patients. This paper has reviewed published literature extensively to understand the pattern, importance, care, and medication.

RESULTS: This review summarizes the association between COVID-19 and diabetes in terms of susceptibility for pneumonia and other diseases. It also discusses the harshness of COVID-19 with diabetes populations and immunological impacts. It further adds the ACE2 receptor role in diabetes with COVID-19 patients.

CONCLUSIONS: Finally, this paper illustrates different types of diabetes management techniques, such as blood glucose management, self-management, mental health management, and therapeutic management. It also summarizes the current knowledge about diabetic patients with COVID-19 to fight this pandemic.

 

Free PDF Download

To cite this article

C. Chakraborty, A.R. Sharma, M. Bhattacharya, G. Sharma, G. Agoramoorthy, S.-S. Lee
Diabetes and COVID-19: a major challenge in pandemic period?

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 21
Pages: 11409-11420
DOI: 10.26355/eurrev_202011_23634